{"doi":"10.1016/j.tins.2007.03.006","title":"Dopamine neuron systems in the brain: an update","abstract":null,"journal":"Trends in Neurosciences","year":2007,"id":41001,"datarank":11.028832240214115,"base_score":7.482681828154651,"endowment":7.482681828154651,"self_citation_contribution":1.1224022742231978,"citation_network_contribution":9.906429965990917,"self_endowment_contribution":1.1224022742231978,"citer_contribution":9.906429965990917,"corpus_percentile":null,"corpus_rank":null,"citation_count":1776,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":25,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":198232,"name":"Stephen B. Dunnett","orcid":null,"position":1,"is_corresponding":false},{"id":170606,"name":"Anders Björklund","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":7.482681828154651,"endowment":7.482681828154651,"datacite_reuse_total":25,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"17408759","pmcid":null,"openalex_id":"https://openalex.org/W2067147530","authors":[],"funders":[{"funder_name":"Medical Research Council","grant_id":"G0500794","title":null}],"total_grants":1,"fwci":17.7783,"citation_percentile":0.99813559,"influential_citations":108,"citation_trend":[{"year":2012,"count":81},{"year":2013,"count":88},{"year":2014,"count":91},{"year":2015,"count":112},{"year":2016,"count":114},{"year":2017,"count":110},{"year":2018,"count":95},{"year":2019,"count":111},{"year":2020,"count":122},{"year":2021,"count":128},{"year":2022,"count":118},{"year":2023,"count":119},{"year":2024,"count":129},{"year":2025,"count":100},{"year":2026,"count":35}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0166223607000677?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0166223607000677?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.tins.2007.03.006","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/17408759","host_type":"repository"},{"url":"https://orca.cardiff.ac.uk/id/eprint/62348/","host_type":"repository"},{"url":"https://lup.lub.lu.se/record/657607","host_type":"repository"}],"fields_of_study":["Neuroscience and Neuropharmacology Research","Receptor Mechanisms and Signaling","Neurotransmitter Receptor Influence on Behavior","Medicine","Psychology","Biology","Animals","Brain","Dopamine","Humans","Immunohistochemistry","Neural Pathways","Neurons"],"mesh_terms":["Animals","Brain","Dopamine","Humans","Immunohistochemistry","Neural Pathways","Neurons"],"keywords":["Neuroscience","Neurochemical","Dopamine","Dopaminergic","Neurotransmitter","Biology","Psychology","Central nervous system"],"sdg_mappings":[],"linked_datasets":[{"doi":"10.6084/m9.figshare.12109785.v1","title":"Additional file 1 of Gray-matter structure in long-term abstinent methamphetamine users","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12109785","title":"Additional file 1 of Gray-matter structure in long-term abstinent methamphetamine users","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12775203.v1","title":"Additional file 1 of Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12775203","title":"Additional file 1 of Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25107725.v1","title":"Additional file 1 of Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25107725","title":"Additional file 1 of Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26573134.v1","title":"Additional file 1 of Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26573134","title":"Additional file 1 of Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26573137.v1","title":"Additional file 2 of Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26573137","title":"Additional file 2 of Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26573140.v1","title":"Additional file 3 of Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26573140","title":"Additional file 3 of Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734863.v1","title":"Additional file 1 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734863","title":"Additional file 1 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734866.v1","title":"Additional file 2 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734866","title":"Additional file 2 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734890.v1","title":"Additional file 4 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734890","title":"Additional file 4 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734893.v1","title":"Additional file 5 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734893","title":"Additional file 5 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734896.v1","title":"Additional file 6 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734896","title":"Additional file 6 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734899.v1","title":"Additional file 7 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734899","title":"Additional file 7 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26734902.v1","title":"Additional file 8 of Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-12T19:58:10.103380Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}